Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes. (Q38786338)

From Wikidata
Jump to navigation Jump to search
scientific article published on 11 March 2016
edit
Language Label Description Also known as
English
Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes.
scientific article published on 11 March 2016

    Statements

    title
    Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    26976796
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26976796%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    10 March 2020

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q38786338&oldid=1576586579"